[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE295157T1 - Mittel zur transdermalen verabreichung von arzneistoffen - Google Patents

Mittel zur transdermalen verabreichung von arzneistoffen

Info

Publication number
ATE295157T1
ATE295157T1 AT97901642T AT97901642T ATE295157T1 AT E295157 T1 ATE295157 T1 AT E295157T1 AT 97901642 T AT97901642 T AT 97901642T AT 97901642 T AT97901642 T AT 97901642T AT E295157 T1 ATE295157 T1 AT E295157T1
Authority
AT
Austria
Prior art keywords
medicinal
agent
drug
transdermal administration
medicine
Prior art date
Application number
AT97901642T
Other languages
English (en)
Inventor
Risto Jaernstroem
Jouni Hirvonen
Original Assignee
Novagent Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI960435A external-priority patent/FI960435A/fi
Priority claimed from FI962450A external-priority patent/FI962450A0/fi
Application filed by Novagent Oy filed Critical Novagent Oy
Application granted granted Critical
Publication of ATE295157T1 publication Critical patent/ATE295157T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97901642T 1996-01-30 1997-01-27 Mittel zur transdermalen verabreichung von arzneistoffen ATE295157T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI960435A FI960435A (fi) 1996-01-30 1996-01-30 Lääkkeiden transdermaalisen antotapaan tarkoitettu koostumus
FI962450A FI962450A0 (fi) 1996-06-12 1996-06-12 Farmaceutisk sammansaettning och foerfarande foer dosering av laekemedel
PCT/FI1997/000039 WO1997027844A1 (en) 1996-01-30 1997-01-27 Composition for transdermal delivery of drugs

Publications (1)

Publication Number Publication Date
ATE295157T1 true ATE295157T1 (de) 2005-05-15

Family

ID=26160098

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97901642T ATE295157T1 (de) 1996-01-30 1997-01-27 Mittel zur transdermalen verabreichung von arzneistoffen

Country Status (7)

Country Link
US (1) US6254883B1 (de)
EP (1) EP0942716B1 (de)
JP (1) JP2000504002A (de)
AT (1) ATE295157T1 (de)
CA (1) CA2242753A1 (de)
DE (1) DE69733268T2 (de)
WO (1) WO1997027844A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI107372B (fi) * 1999-04-29 2001-07-31 Novagent Oy Laite vaikuttavan aineen annosteluun ja annostelun tutkimukseen
EP1480527A4 (de) * 2002-02-13 2005-03-30 Beek Global Ninkov L L C Van Zusammensetzungen und verfahren zur erhöhung der milchproduktion bei tieren
WO2007078007A1 (ja) * 2006-01-06 2007-07-12 Japan Science And Technology Agency カーボンナノホーン構造体並びにその内在有機物の放出を制御可能とする組成物とその方法
JP5558096B2 (ja) 2007-03-01 2014-07-23 株式会社日本触媒 吸水性樹脂を主成分とする粒子状吸水剤
JP5879023B2 (ja) 2007-04-05 2016-03-08 株式会社日本触媒 吸水性樹脂を主成分とする粒子状吸水剤
CN104722101A (zh) * 2010-07-30 2015-06-24 Emd密理博公司 层析介质和方法
FI125075B (fi) 2012-08-13 2015-05-29 Novagent Oy Vaikuttavan aineen iontoforeettinen annostelujärjestelmä
US20150374775A1 (en) * 2013-04-10 2015-12-31 Glycobiosciences Inc. Topical nutraceutical composition
US20210402050A1 (en) * 2020-06-24 2021-12-30 Anika Therapeutics, Inc. Composite medical textile with non-resorbable fibers and bioresorbable hyaluronan-based fibers
EP3188816B1 (de) 2014-09-02 2021-06-09 EMD Millipore Corporation Chromatographie-medum, bestehend aus diskreten porösen bündeln von nanofibrillen
BR112017007942A2 (pt) 2014-10-30 2017-12-19 Textile Based Delivery Inc sistemas de liberação
US20170298091A1 (en) 2014-12-08 2017-10-19 Emd Millipore Corporation Mixed Bed Ion Exchange Adsorber

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE603705C (de) 1931-06-18 1934-10-08 Desider Deutsch Dr Elektrode zur Einfuehrung von Heilmitteln in den Koerper mittels Iontophorese
FI52816C (fi) 1974-03-28 1983-05-10 Exel Oy Trissa foer skidstav
US4032452A (en) 1975-11-13 1977-06-28 Sybron Corporation Electrically regenerated ion exchange system
US4585652A (en) 1984-11-19 1986-04-29 Regents Of The University Of Minnesota Electrochemical controlled release drug delivery system
US4692462A (en) 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US4731049A (en) 1987-01-30 1988-03-15 Ionics, Incorporated Cell for electrically controlled transdermal drug delivery
US5080646A (en) 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5162042A (en) 1988-07-05 1992-11-10 Alza Corporation Electrotransport transdermal system
US5098417A (en) * 1990-04-12 1992-03-24 Ricoh Kyosan, Inc. Cellulosic wound dressing with an active agent ionically absorbed thereon
US5147297A (en) 1990-05-07 1992-09-15 Alza Corporation Iontophoretic delivery device
ATE112496T1 (de) 1991-03-11 1994-10-15 Alza Corp Iontophoretisches verabreichungssystem und verfahren zu seiner herstellung.
WO1994008572A1 (en) 1992-10-15 1994-04-28 Alza Corporation Delayed onset transdermal delivery device
US5603955A (en) 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
EP0739644A4 (de) 1994-09-30 1998-12-09 Advance Kk Schnittstelle für eine transdermale iontophoretische vorrichtung und entsprechendes heilmittel
WO1996010441A1 (en) 1994-09-30 1996-04-11 Becton Dickinson And Company Iontophoretic drug delivery system, including disposable patch and reusable, removable controller

Also Published As

Publication number Publication date
WO1997027844A1 (en) 1997-08-07
EP0942716B1 (de) 2005-05-11
US6254883B1 (en) 2001-07-03
EP0942716A1 (de) 1999-09-22
DE69733268D1 (de) 2005-06-16
DE69733268T2 (de) 2006-01-19
JP2000504002A (ja) 2000-04-04
CA2242753A1 (en) 1997-08-07

Similar Documents

Publication Publication Date Title
GT199900151A (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial.
EP0251680A3 (en) Controlled release bioerodible drug delivery system
DE69506007D1 (de) Transdermales system zur gleichzeitigen verabreichung von mehreren wirkstoffen
DE3650189D1 (de) Mittel zur nichsystemischen Verabreichung von Sedativa und Analgetika.
PT693924E (pt) Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
ES2007100A6 (es) Procedimiento para la obtencion de un sistema terapeutico oral a base de carbamazepina.
NO920832D0 (no) Faststoffmatrikssystem for transdermal medikamentavlevering
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
DE3879853D1 (de) Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien.
ATE295157T1 (de) Mittel zur transdermalen verabreichung von arzneistoffen
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
HUP9901890A2 (hu) Gyógyszer és eljárás szervezet gyógyszeres kezelésére
TR200000149T2 (tr) Serebral nörovasküler bozuklukların, müsküler baş ağrılarının önlenmesine yönelik kompozisyonlar
DE69922017D1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
MY107420A (en) Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances.
ATE208200T1 (de) Transdermales therapeutisches system (tts) zur verabreichung von testosteron
DE59910944D1 (de) Transdermales therapeutisches system zur anwendung von candesartan
AU3278800A (en) Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
DE50010973D1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
AU2503900A (en) Sulfated phosphatidylinositols, their preparation and use
NO963143L (no) Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
DE60028207D1 (de) Transdermales therapeutisches system zur verabreichung von calciumantagonisten
DE69727222D1 (de) Zusammensetzung und system zur iontophoretischen transdermalen abgabe von medikamenten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties